Posts tagged public health
COVID-19 Unmasks Complexities Behind America’s Ailing Healthcare System
COVID-19, Feature, Editors Choice, TechClara MacMahon and Benny Linmcgill business review, mcgill, desautels, desautels faculty of management, MUS, tech & innovation, finance & markets, global news & politics, Clara MacMahon, Benny Lin, healthcare, public health, COVID-19, Coronavirus, private equity, Medicare, Medicaid, insurance, United States of America, Science and Sustainability
The Antibiotics Market is Broken – Can We Fix it?
Editors Choice, TechClara MacMahonmcgill business review, mcgill, desautels, desautels faculty of management, MUS, tech & innovation, finance & markets, global news & politics, antibiotics, big pharma, pharma, healthcare, public health, Clara MacMahon, Science and Sustainability
UK's COVID-19 Strategy Has Fallen Apart
COVID-19, GlobalKayra Akermcgill business review, mcgill, desautels, desautels faculty of management, MUS, tech & innovation, finance & markets, global news & politics, United Kingdom, Boris Johnson, COVID-19, Coronavirus, World Health Organization, public health, national health services, Kayra Aker
The Coronavirus Outbreak: How Worried Should You Be?
Feature, COVID-19, GlobalCindy Hallakmcgill business review, mcgill, desautels, desautels faculty of management, MUS, tech & innovation, finance & markets, global news & politics, Cindy hallak, Coronavirus, COVID-19, World Health Organization, public health, pandemic, China
Universal Pharmacare: A Tough Pill to Swallow
Editors Choice, FinanceSarah Thomasmcgill business review, mcgill, desautels, desautels faculty of management, MUS, tech & innovation, finance & markets, global news & politics, Sarah Thomas, healthcare, public health, pharma, Canada, Economy & Markets 2.0
Can the healthcare sector boost your portfolio’s immune system in 2019?
FinanceSarah Thomasmcgill business review, mcgill, desautels, desautels faculty of management, MUS, tech & innovation, finance & markets, global news & politics, Sarah Thomas, healthcare, public health, stock market, Mutual Funds, NYSE, pharma, Economy & Markets 2.0
